Rating Rationale
January 31, 2020 | Mumbai
Coromandel International Limited
Ratings Reaffirmed
 
Rating Action
Total Bank Loan Facilities Rated Rs.9000 Crore
Long Term Rating CRISIL AA+/Stable (Reaffirmed)
Short Term Rating CRISIL A1+ (Reaffirmed)
 
Rs.2000 Crore Commercial Paper CRISIL A1+ (Reaffirmed)
1 crore = 10 million
Refer to annexure for Details of Instruments & Bank Facilities
Detailed Rationale

CRISIL has reaffirmed its 'CRISIL AA+/Stable/CRISIL A1+' ratings on the bank facilities and commercial paper of Coromandel International Limited (Coromandel).
 
The ratings continue to reflect a robust market position in India's phosphatic-fertiliser market and strong operating efficiency. The ratings also factor in a strong financial risk profile, driven by robust liquidity. These rating strengths are partially offset by exposure to risks related to the regulated nature of the fertiliser industry in India and to volatility in raw material prices.

Analytical Approach

For arriving at the ratings, CRISIL has combined the business and financial risk profiles of Coromandel and its associate and subsidiary companies, considering the operational, managerial and financial linkages between these entities.

Please refer Annexure - List of entities consolidated, which captures the list of entities considered and their analytical treatment of consolidation.

Key Rating Drivers & Detailed Description
Strengths:
* Robust position in India's phosphatic fertiliser market:
The company is the second-largest player in the phosphatic-fertiliser industry in India with a market share of around 17%. Its market position is underpinned by an entrenched and leading position in Andhra Pradesh and Telangana - India's largest complex-fertiliser market - and a wide product portfolio. The company has also been gradually increasing the sale of non-subsidy-based products, including crop protection, speciality nutrients (secondary and micro-nutrients [sulphur, zinc, calcium, and boron], water-soluble fertilisers, and compost), and gypsum (a by-product from the manufacture of phosphoric acid). During April 2018, it also acquired the bio-pesticides business of E.I.D. Parry India Ltd ('CRISIL AA-/Stable/CRISIL A1+'), along with the latter's wholly owned subsidiary, Parry America, Inc, USA, which has further diversified the product profile under the crop protection business. The company's brand, Gromor, has strong recall among customers and commands a premium in its key markets. It also has its own retail outlets, Mana Gromor Centres, through which it sells fertilisers, crop protection chemicals, speciality nutrient products, seeds, sprayers, veterinary products, and others. It has around 800 stores in Andhra Pradesh, Telangana, Karnataka, and Maharashtra.

* Strong operating efficiency:
Operations derive benefits from economies of scale, assured raw material procurement due to an established relationship with suppliers, captive production of phosphoric acid, superior plant infrastructure, and low handling and transportation costs. Expansion of the phosphoric acid capacity of the Vishakhapatnam plant has been completed in October 2019, thus making this unit self-sufficient. The operating efficiency is also supported by the ability to adjust the product mix (between di-ammonium phosphate and other complex fertilisers).
 
Increasing share of non-subsidy-based products, such as specialty nutrients, crop protection, and retail business has also reduced vulnerability of profits to changes in the government's subsidy policies. The EBITDA (earnings before interest, tax, depreciation, and amortisation) margin remained healthy during fiscal 2019 at 10.7% as against 11.2% in the previous fiscal. The margin has improved further to 13.2% in the first half of fiscal 2020 and is expected to remain healthy over the medium term as well.
 
* Strong financial risk profile:
The debt protection metrics are comfortable and the capital structure healthy. The interest coverage and net cash accrual to total debt ratios were at 5.79 times and 0.20 time, respectively, in fiscal 2019, as against 7.20 times and 0.18 time, respectively, in fiscal 2018. Absence of any long-term debt, and any capital expenditure (capex) or acquisition being funded through internal cash accruals, have kept the gearing below 1 time (0.89 time as on March 31, 2019). Further, all the borrowings are for working capital, largely to fund subsidy delays, inventory, and market receivables.
 
The gearing is expected to remain comfortable at below 1 time over the medium term, in the absence of any long-term debt and despite higher working capital requirement to fund any delay in government subsidy receivables. Any larger-than-expected debt-funded capex or acquisition, or higher working capital borrowing, adversely impacting the financial risk profile, will remain a key monitorable.
 
Weakness:
* Exposure to the regulated nature of the fertiliser industry and volatility in raw material prices:
The fertiliser industry is strategic, but highly controlled, with fertiliser subsidy being an important component of profitability. The phosphatic fertiliser industry was brought under the nutrient-based subsidy (NBS) regime from April 1, 2010. Under this scheme, the Government of India fixes the subsidy payable on nutrients for the entire fiscal (with an option to review this every six months), while retail prices are market-driven. Manufacturers of phosphatic fertilisers are dependent on imports for their key raw materials, such as rock phosphate and phosphoric acid. The cost of raw materials accounts for about 70% of the operating income. The regulated nature of the industry and susceptibility of complex fertiliser players (including Coromandel) to raw material price volatility under the NBS regime continues to be a key rating sensitivity factor. Additionally, any delay in disbursement of subsidy under the direct benefit transfer scheme may lead to significant reliance on short-term working capital borrowing, leading to high interest costs; this too remains a key rating sensitivity factor.
Liquidity Strong

Cash and cash equivalents were Rs 590 crore as on March 31, 2019. The bank limit of about Rs 3,410 crore was utilised at an average of about 70% during the 12 months through December 2019. Cash accrual was healthy at Rs 605 crore, as against nil maturing debt, in fiscal 2019. Expectation of cash accrual of Rs 800'900 crore per fiscal with no term debt repayment over the medium term, further supports liquidity.

Outlook: Stable

CRISIL believes Coromandel will generate steady cash flows over the medium term, backed by strong operating efficiency, lower raw material prices, and higher offtake volume. The capital structure is also expected to remain healthy over this period in the absence of any long-term debt.

Rating Sensitivity factors
Upward factors:
* Increase in the scale of operations and market share, along with sustainable improvement in profitability
* Sustained improvement in the financial risk profile on account of reduction in debtors to below 50 days
 
Downward factors:
* Sustained weakening of the operating performance, caused by any unfavourable impact of governmental policies
* Large debt-funded capex or acquisitions, leading to overall leverage exceeding 1.5 times
About the Company

Coromandel, one of the flagship companies of the Murugappa group, was established as a private company in 1961. At present, E.I.D. Parry (India) Ltd, a Murugappa group company, owns 60.55% of Coromandel.
 
The company's business structure is bifurcated into two segments: nutrient and other allied businesses and crop protection business. The nutrient and other allied segment includes the manufacturing & marketing of complex fertilisers, speciality nutrients, organic fertilisers, and the retail business that provides agricultural inputs and services. The crop protection business includes manufacture of bio-based and chemical pesticides.
 
The company has the capacity to manufacture over 4.5 million tonne of fertilisers and pesticides and 1 million tonne of single super phosphate per annum.

Key Financial Indicators
Particulars Unit 2019 2018
Revenue Rs crore 13,216 10,946
Profit after tax (PAT) Rs crore 720 664
PAT margin % 5.45 6.06
Adjusted debt/adjusted networth Times 0.89 0.88
Interest coverage Times 5.79 7.20

Any other information: Not applicable

Note on complexity levels of the rated instrument:
CRISIL complexity levels are assigned to various types of financial instruments. The CRISIL complexity levels are available on www.crisil.com/complexity-levels. Users are advised to refer to the CRISIL complexity levels for instruments that they consider for investment. Users may also call the Customer Service Helpdesk with queries on specific instruments.
Annexure - Details of Instrument(s)
ISIN Name of instrument Date of allotment Coupon rate (%) Maturity date Issue size (Rs crore) Rating assigned
with outlook
NA Cash Credit@@ NA NA NA 750 CRISIL AA+/Stable
NA Cash Credit$$ NA NA NA 650 CRISIL AA+/Stable
NA Cash Credit$ NA NA NA 50 CRISIL AA+/Stable
NA Cash Credit%% NA NA NA 500 CRISIL AA+/Stable
NA Cash Credit# NA NA NA 80 CRISIL AA+/Stable
NA Buyer's Credit Limit NA NA NA 140 CRISIL A1+
NA Letter of Credit & Bank Guarantee 1 NA NA NA 800 CRISIL AA+/Stable
NA Letter of Credit & Bank Guarantee 2 NA NA NA 1100 CRISIL A1+
NA Letter of Credit & Bank Guarantee 3 NA NA NA 70 CRISIL A1+
NA Letter of Credit & Bank Guarantee 4 NA NA NA 2000 CRISIL A1+
NA Letter of Credit & Bank Guarantee NA NA NA 750 CRISIL A1+
NA Short Term Loan NA NA NA 1000 CRISIL A1+
NA Short Term Loan$ NA NA NA 300 CRISIL A1+
NA Short Term Loan% NA NA NA 300 CRISIL A1+
NA Working Capital Demand Loan* NA NA NA 100 CRISIL AA+/Stable
NA Proposed Fund-Based Bank Limits NA NA NA 100 CRISIL AA+/Stable
NA Proposed Non-Fund Based Bank Limits NA NA NA 310 CRISIL A1+
NA Commercial paper NA NA 7-365 days 2000 CRISIL A1+
@@ Fully interchangeable with short term loan and non-letter of credit reimbursement finance (NLRF) limit up to Rs. 500 crore.
$$ Interchangeable with short term loan and non-fund based limits up to Rs. 400 crore.
$ Fully interchangeable with letter of credit limits
%% Limits sanctioned USD 70 Million. Fully interchangeable with letter of credit, bank guarantee, short term loan and buyers credit
%Fully interchangeable with LC & SBLC
* Fully interchangeable with LC, SBLC and interchangeable with CC
#Limits sanctioned Rs 80 crores under corporate commercial card
(1) Fully interchangeable with fund based facility/buyers credit upto Rs. 800 crore and interchangeable with bank guarantee limit up to Rs. 400 crore and overdraft limits upto 10 crore
(2) Interchangeable with stand-by letter of credit (SBLC) upto Rs 500 crore.
(3) Limits sanctioned USD 10 Million. Fully interchangeable with SBLC limits and short term loan limit up to Rs. 30 crore
(4) Interchangeable with SBLC upto Rs. 1000 crore
 
Annexure - List of entities consolidated
Names of entities consolidated Extent of consolidation Rationale for consolidation
Liberty Pesticides and Fertilisers Ltd Fully consolidated Strong financial and business linkages
Sabero Organics America S.A. Fully consolidated Strong financial and business linkages
Sabero Australia Pty Ltd Fully consolidated Strong financial and business linkages
Sabero Europe B.V. Fully consolidated Strong financial and business linkages
Sabero Argentina S.A. Fully consolidated Strong financial and business linkages
Coromandel Agronegocios de Mexico, S.A de C.V Fully consolidated Strong financial and business linkages
Parry Chemicals Ltd Fully consolidated Strong financial and business linkages
Dare Investments Ltd Fully consolidated Strong financial and business linkages
CFL Mauritius Ltd Fully consolidated Strong financial and business linkages
Coromandel Brasil Ltda Fully consolidated Strong financial and business linkages
Parry America Inc Fully consolidated Strong financial and business linkages
Coromandel International (Nigeria) Limited Fully consolidated Strong financial and business linkages
Coromandel SQM (India) Pvt Ltd Equity method Proportionate consolidation
Yanmar Coromandel Agrisolutions Pvt Ltd Equity method Proportionate consolidation
Sabero Organics Philippines Asia Inc Equity method Proportionate consolidation
Annexure - Rating History for last 3 Years
  Current 2020 (History) 2019  2018  2017  Start of 2017
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Commercial Paper  ST  2000.00  CRISIL A1+      31-01-19  CRISIL A1+  03-01-18  CRISIL A1+  30-12-17  CRISIL A1+  -- 
Short Term Debt (Including Commercial Paper)  ST                      CRISIL A1+ 
Fund-based Bank Facilities  LT/ST  3970.00  CRISIL AA+/Stable/ CRISIL A1+      31-01-19  CRISIL AA+/Stable/ CRISIL A1+  03-01-18  CRISIL AA+/Stable/ CRISIL A1+  30-12-17  CRISIL AA+/Stable/ CRISIL A1+  CRISIL AA+/Stable/ CRISIL A1+ 
Non Fund-based Bank Facilities  LT/ST  5030.00  CRISIL AA+/Stable/ CRISIL A1+      31-01-19  CRISIL A1+  03-01-18  CRISIL A1+  30-12-17  CRISIL A1+  CRISIL A1+ 
All amounts are in Rs.Cr.
Annexure - Details of various bank facilities
Current facilities Previous facilities
Facility Amount (Rs.Crore) Rating Facility Amount (Rs.Crore) Rating
Buyer`s Credit 140 CRISIL A1+ Buyer`s Credit 140 CRISIL A1+
Cash Credit@@ 750 CRISIL AA+/Stable Cash Credit@@ 750 CRISIL AA+/Stable
Cash Credit$$ 650 CRISIL AA+/Stable Cash Credit$$ 650 CRISIL AA+/Stable
Cash Credit$ 50 CRISIL AA+/Stable Cash Credit** 50 CRISIL AA+/Stable
Cash Credit%% 500 CRISIL AA+/Stable Cash Credit%% 490 CRISIL AA+/Stable
Cash Credit# 80 CRISIL AA+/Stable Proposed Fund-Based Bank Limits 425 CRISIL AA+/Stable
Letter of credit & Bank Guarantee1 800 CRISIL AA+/Stable Letter of credit & Bank Guarantee7 800 CRISIL A1+
Letter of credit & Bank Guarantee2 1100 CRISIL A1+ Letter of credit & Bank Guarantee2 1100 CRISIL A1+
Letter of credit & Bank Guarantee3 70 CRISIL A1+ Letter of credit & Bank Guarantee3 70 CRISIL A1+
Letter of credit & Bank Guarantee4 2000 CRISIL A1+ Letter of credit & Bank Guarantee4 2000 CRISIL A1+
Letter of credit & Bank Guarantee 750 CRISIL A1+ Letter of credit & Bank Guarantee 750 CRISIL A1+
Proposed Fund-Based Bank Limits 100 CRISIL AA+/Stable Letter of credit & Bank Guarantee5 400 CRISIL A1+
Working Capital Demand Loan* 100 CRISIL AA+/Stable Letter of credit & Bank Guarantee6 275 CRISIL A1+
Proposed Non Fund based limits 310 CRISIL A1+ Short Term Loan 800 CRISIL A1+
Short Term Loan 1000 CRISIL A1+ Short Term Loan$ 300 CRISIL A1+
Short Term Loan$ 300 CRISIL A1+ -- 0 --
Short Term Loan% 300 CRISIL A1+ -- 0 --
Total 9000 -- Total 9000 --
@@ Fully interchangeable with short term loan and non-letter of credit reimbursement finance (NLRF) limit up to Rs. 500 crore.
$$ Interchangeable with short term loan and non-fund based limits up to Rs. 400 crore.
$ Fully interchangeable with letter of credit limits
%% Limits sanctioned USD 70 Million. Fully interchangeable with letter of credit, bank guarantee, short term loan and buyers credit
% Fully interchangeable with LC & SBLC
* Fully interchangeable with LC, SBLC and interchangeable with CC
#Limits sanctioned Rs 80 crores under corporate commercial card
** Fully interchangeable with short term loan, non-fund based and buyers credit limits
(1) Fully interchangeable with fund based facility/buyers credit upto Rs. 800 crore and interchangeable with bank guarantee limit up to Rs. 400 crore and overdraft limits upto 10 crore
(2) Interchangeable with stand-by letter of credit (SBLC) upto Rs 500 crore.
(3) Limits sanctioned USD 10 Million. Fully interchangeable with SBLC limits and short term loan limit up to Rs. 30 crore
(4) Interchangeable with SBLC upto Rs. 1000 crore
(5) Fully Interchangeable to Fund Based Facility and Buyers Credit
(6) Interchangeable to overdraft (OD) upto Rs 5 crore
(7) Fully interchangeable with fund based facility/buyers credit upto Rs. 800 crore and interchangeable with bank guarantee limit up to Rs. 400 crore
Links to related criteria
CRISILs Approach to Financial Ratios
CRISILs Bank Loan Ratings - process, scale and default recognition
Rating criteria for manufaturing and service sector companies
Rating Criteria for Fertiliser Industry
CRISILs Bank Loan Ratings
CRISILs Criteria for Consolidation
CRISILs Criteria for rating short term debt

For further information contact:
Media Relations
Analytical Contacts
Customer Service Helpdesk
Saman Khan
Media Relations
CRISIL Limited
D: +91 22 3342 3895
B: +91 22 3342 3000
saman.khan@crisil.com

Naireen Ahmed
Media Relations
CRISIL Limited
D: +91 22 3342 1818
B: +91 22 3342 3000
naireen.ahmed@crisil.com

Sachin Gupta
Senior Director - CRISIL Ratings
CRISIL Limited
D:+91 22 3342 3023
Sachin.Gupta@crisil.com


Nitesh Jain
Director - CRISIL Ratings
CRISIL Limited
D:+91 22 3342 3329
nitesh.jain@crisil.com


Joanne Gonsalves
Rating Analyst - CRISIL Ratings
CRISIL Limited
D:+91 22 4254 4071
Joanne.Gonsalves@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper / magazine / agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL. However, CRISIL alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites, portals etc.


About CRISIL Limited

CRISIL is a leading agile and innovative, global analytics company driven by its mission of making markets function better. We are India’s foremost provider of ratings, data, research, analytics and solutions. A strong track record of growth, culture of innovation and global footprint sets us apart. We have delivered independent opinions, actionable insights, and efficient solutions to over 1,00,000 customers.
 
We are majority owned by S&P Global Inc., a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.
 
For more information, visit www.crisil.com 


Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK

About CRISIL Ratings
CRISIL Ratings is part of CRISIL Limited (“CRISIL”). We pioneered the concept of credit rating in India in 1987. CRISIL is registered in India as a credit rating agency with the Securities and Exchange Board of India (“SEBI”). With a tradition of independence, analytical rigour and innovation, CRISIL sets the standards in the credit rating business. We rate the entire range of debt instruments, such as, bank loans, certificates of deposit, commercial paper, non-convertible / convertible / partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 24,500 large and mid-scale corporates and financial institutions. CRISIL has also instituted several innovations in India in the rating business, including rating municipal bonds, partially guaranteed instruments and microfinance institutions. We also pioneered a globally unique rating service for Micro, Small and Medium Enterprises (MSMEs) and significantly extended the accessibility to rating services to a wider market. Over 1,10,000 MSMEs have been rated by us.


CRISIL PRIVACY
 
CRISIL respects your privacy. We may use your contact information, such as your name, address, and email id to fulfil your request and service your account and to provide you with additional information from CRISIL.For further information on CRISIL’s privacy policy please visit www.crisil.com.


DISCLAIMER

This disclaimer forms part of and applies to each credit rating report and/or credit rating rationale that we provide (each a “Report”). For the avoidance of doubt, the term “Report” includes the information, ratings and other content forming part of the Report. The Report is intended for the jurisdiction of India only. This Report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the Report is to be construed as CRISIL providing or intending to provide any services in jurisdictions where CRISIL does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this Report does not create a client relationship between CRISIL and the user.

We are not aware that any user intends to rely on the Report or of the manner in which a user intends to use the Report. In preparing our Report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the Report is not intended to and does not constitute an investment advice. The Report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind or otherwise enter into any deal or transaction with the entity to which the Report pertains. The Report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Rating are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities / instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL assumes no obligation to update its opinions following publication in any form or format although CRISIL may disseminate its opinions and analysis. CRISIL rating contained in the Report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the Report should rely on their own judgment and take their own professional advice before acting on the Report in any way.CRISIL or its associates may have other commercial transactions with the company/entity.

Neither CRISIL nor its affiliates, third party providers, as well as their directors, officers, shareholders, employees or agents (collectively, “CRISIL Parties”) guarantee the accuracy, completeness or adequacy of the Report, and no CRISIL Party shall have any liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the Report. EACH CRISIL PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the Report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. CRISIL’s public ratings and analysis as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any) are made available on its web sites, www.crisil.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee – more details about CRISIL ratings are available here: www.crisilratings.com.

CRISIL and its affiliates do not act as a fiduciary. While CRISIL has obtained information from sources it believes to be reliable, CRISIL does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and / or relies in its Reports. CRISIL keeps certain activities of its business units separate from each other in order to preserve the independence and objectivity of the respective activity. As a result, certain business units of CRISIL may have information that is not available to other CRISIL business units. CRISIL has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL has in place a ratings code of conduct and policies for analytical firewalls and for managing conflict of interest. For details please refer to: https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html

CRISIL’s rating criteria are generally available without charge to the public on the CRISIL public web site, www.crisil.com. For latest rating information on any instrument of any company rated by CRISIL you may contact CRISIL RATING DESK at CRISILratingdesk@crisil.com, or at (0091) 1800 267 1301.

This Report should not be reproduced or redistributed to any other person or in any form without a prior written consent of CRISIL.

All rights reserved @ CRISIL